<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2853">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04452422</url>
  </required_header>
  <id_info>
    <org_study_id>7908</org_study_id>
    <nct_id>NCT04452422</nct_id>
  </id_info>
  <brief_title>Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology</brief_title>
  <acronym>VT-Covid-19</acronym>
  <official_title>High Prevalence of Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe SARS-CoV-2 infection, responsible of COVID-19, is accompanied by many venous
      thromboembolic events. Antithrombotic treatment is the cornerstone of management of many
      neurovascular diseases (NVDs) and the benefit-risk ratio is crucial to avoid hemorrhagic
      complications. Therefore, in non-severe COVID-19 patients affected by NVDs, the diagnostic of
      deep venous thrombosis (DVT) is challenging. Using bedside Doppler ultrasonography (DUS) of
      lower limbs, this study investigated the rates of DVT in these patients in stroke unit.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 23, 2020</start_date>
  <completion_date type="Anticipated">September 23, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 23, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of cumulated deep venous thrombosis among the hospitalization</measure>
    <time_frame>Day 7 after admisssion</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Deep Venous Thrombosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with COVID-19 confirmed with RT-PCER and/or chest CT-scan and with acute
        neurovascular disease defined as transient ischemic attack or acute ischemic stroke or
        venous cerebral thrombosis or hemorrhagic stroke.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  Inclusion criteria:

               -  Age&gt;18 years

               -  COVID-19 confirmed with RT-PCER and/or chest CT-scan

               -  Acute neurovascular disease defined as transient ischemic attack or acute
                  ischemic stroke or venous cerebral thrombosis or hemorrhagic stroke.

          -  Exclusion criteria:

               -  age&lt;18

               -  Other neurovascular diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Olivier ROUYER, MD</last_name>
    <phone>33 3 88 12 87 50</phone>
    <email>olivier.rouyer@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Unité Neurovasculaire</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier ROUYER, MD</last_name>
      <phone>33 3 88 12 87 50</phone>
      <email>olivier.rouyer@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
      <phone>33 3 88 11 66 90</phone>
      <email>said.chayer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Olivier ROUYER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard GENY, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nora PIERRE-PAUL Irène, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amadou Talibe BALDE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniela BINDILA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie WOLFF, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 23, 2020</study_first_submitted>
  <study_first_submitted_qc>June 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2020</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non-severe COVID-19</keyword>
  <keyword>neurovascular diseases</keyword>
  <keyword>Doppler ultrasound</keyword>
  <keyword>Deep venous thrombosis</keyword>
  <keyword>Covid-19</keyword>
  <keyword>SARS-CoV-2</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

